Psychiatr. pro Praxi, 2003; 3: 94-100

Sexuální dysfunkce při léčbě antidepresivy

MUDr. Michal Maršálek CSc
Psychiatrická léčebna Bohnice, Praha

Keywords: antidepressants, drug-induced sexual dysfunctions, prevalence, treatment.

Published: December 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Maršálek M. Sexuální dysfunkce při léčbě antidepresivy. Psychiatr. praxi. 2003;4(3):94-100.

Rizika sexuálních dysfunkcí (SD) indukovaných antidepresivy nejsou zatím dostatečně prozkoumána. Podle současných znalostí se zdá, že by mohla existovat skupina antidepresiv s vyšším rizikem SD, kam patří preparáty s převahou serotoninergního působení, a skupina s nižším rizikem, u které převažuje antiserotoninový efekt, dopaminergní a snad i noradrenergní působení. Do skupiny s předpokládaným vyšším rizikem SD patří tricyklická antidepresiva, IMAO, SSRI a SNRI. Skupinu s patrně nižším rizikem SD tvoří RIMA (moklobemid), SARI (nefazodon a trazodon), NaSSA (mirtazapin), NARI (reboxetin), NDRI (bupropion), SRE (tianeptin) a extrakt třezalky (Hypericum perforatum). Nefazodon, trazodon a mirtazapin jsou využívány v přídatné léčbě SD. Při sexuálních potížích po AD je možné nemocné převést na antidepresivum s nižším rizikem sexuálních poruch.

Antidepressant - indued sexual dysfunction

Risk of antidepressant-induced sexual dysfunctions (SD) is not yet sufficiently explored. According to our present knowledge, agents with mainly serotonergic effect might be associated with higher rates of sexual dysfunctions than antiserotonergic, dopaminergic, and probably noradrenergic drugs. A higher risk of sexual dysfunctions is supposed in a group of tricyclic antidepressants, IMAO, SSRI, and SNRI. In contrast, RIMA (moclobemide), SARI (nefazodone a trazodone), NaSSA (mirtazapine), NARI (reboxetine), NDRI (bupropione), SRE (tianeptine), and St. John-s wort extract (Hypericum perforatum) probably represent a low-risk subgroup. Nefazodone, trazodone and mirtazapine are used as adjunctive treatment for SD. When sexual side effects occur, it is possible to replace a problematic antidepressant with other agent with less sexual dysfunction.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Balon R, Yeragani VK, Pohl R, Ramesh C. Sexual dysfunction during antidepressant treatment. J Clin Psychiatry 1993; 54: 209-212.
    2. Casper RC, Redmond E, Katz MM, et al. Somatic symptoms in primary affective disorders: presence and relationship to the classification of depression. Arch Gen Psychiatry 1985; 42: 1098-1104. Go to original source... Go to PubMed...
    3. Ducrocq F. Depression and sexual disorders. Encephale 1999; 25: 515-516. Go to PubMed...
    4. Eskelius L, von Knorring L. Effect on sexual function of long-term treatment with selective serotonin inhibitors in depressed patients treated in primary care. J Clin Psychopharmacol 2001; 21: 154-160. Go to original source... Go to PubMed...
    5. Ferguson JM. The effect of antidepressants on sexual functioning in depressed patients: a review. J Clin Psychiatry 2001; 62 (Suppl 3): 22-34.
    6. Gelenberg AJ, Laukes C, McGahuey C, et al. Mirtazapine substitution in SSRI-induced sexual dysfunction. J Clin Psychiatry 2000; 61: 356-360. Go to original source... Go to PubMed...
    7. Gitlin MJ. Psychotropic medication and their effects on sexual function: diagnosis, biology, and treatment approaches. J Clin Psychiatry 1994; 55: 406-413.
    8. Grube B, Walper A, Wheatley D. St. John's wort extract: efficacy for menopausal symptom of psychological origin. Adv Ther 1999; 16: 177-186.
    9. Hallward A, Ellison JM. Antidepressants and sexual function. 2001 Harcourt Health Communiction, London, 92 pp.
    10. Harrison WM, Rabkin JG, Ebrhardt AA, et al. Effects of antidepressant medication on sexual function: a controlled study. J Clin Psychopharmacol 1986; 6: 144-149. Go to original source... Go to PubMed...
    11. Kennedy SH, Ralevski E, Davis C, Neitzert C. The effect of moclobemide on sexual desire and function in healthy volunteers. Eur Neuropsychopharmacol 1996; 6: 177-181. Go to original source... Go to PubMed...
    12. Koutouvidis A, Pratikakis M, Fotiadou A. The use of mirtazapine in a group of 11 patients following poor compliance to selective serotonin reuptake inhibitor treatment due to sexual dysfunction. Int Clin Psychopharmacol 1999; 14: 253-255. Go to original source... Go to PubMed...
    13. Labbate LA, Brodrick PS, Nelon RP, et al. Effects of bupropion sustained-release on sexual functioning and nocturnal erections in healthy men. J Clin Psychopharmacol 2001; 21: 99-103. Go to original source... Go to PubMed...
    14. Maršálek M. Tardive drug-induced extrapyramidal syndromes. Pharmacopsychiatry 2000; 33 (Suppl 1): 14-33. Go to original source... Go to PubMed...
    15. Modell JG, Katholi CR, Modell JD, DePalma RL. Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline. Clin Pharmacol Ther 1997; 61: 476-487. Go to original source... Go to PubMed...
    16. Modell JG, May RS, Katholi CR. Effect of bupropion-SR on orgasmic dysfunction in nondepressed subjects: a pilot study. J Sex Marital Ther 2000; 26: 231-240. Go to original source... Go to PubMed...
    17. Monteiro WO, Noshrivani HF, Marks IM, et al. Anorgasmia from clomipramine in obsessive compulsive disorder: a controlled trial. Br J Psychiatry 1987; 151: 107-112. Go to original source... Go to PubMed...
    18. Montejo AL, Llorca G, Izquierdo JA, et al. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. J Clin Psychiatry 2001; 62 (Suppl 3): 10-21.
    19. Montejo-González AL, Llorca G, Izquierdo JA, et al. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 1997; 23: 176-194. Go to original source... Go to PubMed...
    20. Montgomery SA. Safety of mirtazapine: a review. Int Clin Psychopharmacol 1995; 10 (Suppl 4): 37-45. Go to original source... Go to PubMed...
    21. Montgomery SA, Baldwin DS, Riley A. Antidepressant medication: a review of the evidence for drug-induced sexual dysfunction. J Affect Dis 2002; 69: 119-140. Go to original source... Go to PubMed...
    22. Nieuwstraten CE, Dolovich LR. Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression. Ann Pharmacother 2001; 35: 1608-1613. Go to original source... Go to PubMed...
    23. Nurnberg HG. Managing treatment-emergent sexual dysfunction associated with serotonergic antidepressants: before and after sildenafil. J Psychiatr Practice 2001; 7: 92-108. Go to original source... Go to PubMed...
    24. Philipp M, Tiller JW, Baier D, et al. Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. The Australian and German Study Group. Eur Neuropsychopharmacol 2000; 10: 305-314. Go to original source... Go to PubMed...
    25. Reimherr FW, Chouinard G, Cohn CK, et al. Antidepressant efficacy of sertraline: a double-blind, placebo - and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. J Clin Psychiatry 1990; 51 (Suppl B): 18-27.
    26. Rothschild AJ. Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday. Am J Psychiatry 1995; 152: 1514-1516. Go to original source... Go to PubMed...
    27. Rothschild AJ. Sexual dysfunction associated with depression. J Clin Psychiatry 2001; 62 (Suppl 3): 3-4.
    28. Švestka J. Třezalka tečkovaná (Hypericum perforatum linn) - rostlinné antidepresivum. Psychiatrie 2002; 6: 109-120.
    29. Tanum L. Reboxetine: tolerability and safety profile in patients with major depression. Acta Psychiatr Scand 2000; 402 (Suppl): 37-40. Go to original source... Go to PubMed...
    30. Waldinger MD, Hengeveld MW, Zwinderman AH. Effect of SSRI antidepressants on ejaculation: a double-blind, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol 1998; 18: 274-281. Go to original source... Go to PubMed...
    31. Zajecka J, Mitchel S, Fawcett J. Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory. Psychopharmacol Bull 1997; 33: 755-760. Go to PubMed...
    32. Žourková A. Klinický význam CYP 2D6 v průběhu léčby novějšími antidepresivy. CS Psychiatr 2002; 98: 273-277.

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.